1H-30

N/A

Report date: 2022/07/26 14:42:45
NME

Base Information

Drug Name1H-30
Drug Alias Name1H-30
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclooxygenase-2 inhibitorsDNA topoisomerase I inhibitors
TargetsCyclooxygenase-2DNA topoisomerase I
Therapy Area/IndicationsGastrointestinal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesLanzhou University
China Registration ClassN/A

Develop Information

Active CompaniesLanzhou University
Inactive CompaniesN/A
Active IndicationsGastrointestinal Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A